Maternal mortality in well-resourced countries: is there still a need for confidential enquiries?

Best Practice & Research. Clinical Obstetrics & Gynaecology
J Drife

Abstract

The low maternal mortality rates in well-resourced countries are not an automatic consequence of prosperity. Morbidity cannot be avoided and preventing mortality requires good medical care. Now that deaths are infrequent in these countries, people expect investigation of every case and action to make pregnancy even safer. Confidential enquiries do this, and are appropriate when mortality rates are low enough for scrutiny of individual cases. Confidential enquiries have major advantages over other methods of investigation such as public enquiry or hospital audit. The function of confidential enquiries is to improve care, not apportion blame, and they receive frank comments as well as full facts. Analysis is by practising clinicians from many specialties and recommendations are disseminated to clinicians, managers, politicians and the public. The confidential enquiry method has now been adopted by other specialties and by many countries. In countries without confidential enquiries there is under-reporting of maternal mortality, particularly among the poor.

References

Dec 1, 1984·American Journal of Obstetrics and Gynecology·A M KaunitzD A Grimes
Oct 30, 1993·BMJ : British Medical Journal·J O Drife
Jun 27, 1998·European Journal of Obstetrics, Gynecology, and Reproductive Biology·N SchuitemakerJ Bennebroek Gravenhorst
Oct 8, 1998·British Journal of Obstetrics and Gynaecology·T F Baskett, J Sternadel
May 20, 2000·JAMA : the Journal of the American Medical Association·K NagayaR Neki
Jan 12, 2002·JAMA : the Journal of the American Medical Association·Trude Bennett
Feb 13, 2002·Kennedy Institute of Ethics Journal·UNKNOWN National Reference Center for Bioethics Literature
Jun 18, 2002·BMJ : British Medical Journal·F DabisUNKNOWN Working Group on Women and Child Health
Jan 9, 2004·British Medical Bulletin·Nynke van den Broek
Oct 7, 2004·International Journal of Epidemiology·Oliver Razum, Hajo Zeeb
Sep 6, 2005·BMJ : British Medical Journal·Justin O ParkhurstDina Balabanova
Dec 21, 2005·Seminars in Fetal & Neonatal Medicine·James Owen Drife
Mar 28, 2006·British Journal of Hospital Medicine·James Drife

❮ Previous
Next ❯

Citations

Apr 9, 2010·BJOG : an International Journal of Obstetrics and Gynaecology·J J Walker
Jun 17, 2015·International Journal of Health Services : Planning, Administration, Evaluation·Peter DuncanFrancisco Oscar de Siqueira França
Jul 5, 2015·Maternal and Child Health Journal·Stacie E GellerUNKNOWN Illinois Department of Public Health Maternal Mortality Review Committee Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
R Cook
Best Practice & Research. Clinical Obstetrics & Gynaecology
J van Roosmalen, Joost Zwart
European Journal of Obstetrics, Gynecology, and Reproductive Biology
M H Bouvier-ColleG Bréart
BJOG : an International Journal of Obstetrics and Gynaecology
J M SchutteNetherlands Maternal Mortality Committee
© 2021 Meta ULC. All rights reserved